213 related articles for article (PubMed ID: 22359398)
1. Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging.
Sánchez-Castañeda C; Cherubini A; Elifani F; Péran P; Orobello S; Capelli G; Sabatini U; Squitieri F
Hum Brain Mapp; 2013 Jul; 34(7):1625-35. PubMed ID: 22359398
[TBL] [Abstract][Full Text] [Related]
2. The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.
Sánchez-Castañeda C; Squitieri F; Di Paola M; Dayan M; Petrollini M; Sabatini U
Hum Brain Mapp; 2015 Jan; 36(1):50-66. PubMed ID: 25145324
[TBL] [Abstract][Full Text] [Related]
3. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
4. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
Majid DS; Aron AR; Thompson W; Sheldon S; Hamza S; Stoffers D; Holland D; Goldstein J; Corey-Bloom J; Dale AM
Mov Disord; 2011 Dec; 26(14):2544-51. PubMed ID: 21932302
[TBL] [Abstract][Full Text] [Related]
5. Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients.
Syka M; Keller J; Klempíř J; Rulseh AM; Roth J; Jech R; Vorisek I; Vymazal J
PLoS One; 2015; 10(3):e0118907. PubMed ID: 25781024
[TBL] [Abstract][Full Text] [Related]
6. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
[TBL] [Abstract][Full Text] [Related]
7. Diffusion imaging studies of Huntington's disease: A meta-analysis.
Liu W; Yang J; Burgunder J; Cheng B; Shang H
Parkinsonism Relat Disord; 2016 Nov; 32():94-101. PubMed ID: 27624391
[TBL] [Abstract][Full Text] [Related]
8. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
Johnson EB; Parker CS; Scahill RI; Gregory S; Papoutsi M; Zeun P; Osborne-Crowley K; Lowe J; Nair A; Estevez-Fraga C; Fayer K; Rees G; Zhang H; Tabrizi SJ;
EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
[TBL] [Abstract][Full Text] [Related]
9. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
[TBL] [Abstract][Full Text] [Related]
10. Increased basal ganglia iron levels in Huntington disease.
Bartzokis G; Cummings J; Perlman S; Hance DB; Mintz J
Arch Neurol; 1999 May; 56(5):569-74. PubMed ID: 10328252
[TBL] [Abstract][Full Text] [Related]
11. Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study.
Domínguez JF; Ng AC; Poudel G; Stout JC; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
J Neurol Neurosurg Psychiatry; 2016 May; 87(5):545-9. PubMed ID: 25952334
[TBL] [Abstract][Full Text] [Related]
12. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.
Sritharan A; Egan GF; Johnston L; Horne M; Bradshaw JL; Bohanna I; Asadi H; Cunnington R; Churchyard AJ; Chua P; Farrow M; Georgiou-Karistianis N
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):257-62. PubMed ID: 19237387
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
Eustache P; Nemmi F; Saint-Aubert L; Pariente J; Péran P
J Alzheimers Dis; 2016; 50(4):1035-50. PubMed ID: 26836151
[TBL] [Abstract][Full Text] [Related]
15. MRI measures of corpus callosum iron and myelin in early Huntington's disease.
Di Paola M; Phillips OR; Sanchez-Castaneda C; Di Pardo A; Maglione V; Caltagirone C; Sabatini U; Squitieri F
Hum Brain Mapp; 2014 Jul; 35(7):3143-51. PubMed ID: 24895252
[TBL] [Abstract][Full Text] [Related]
16. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging in Huntington's disease.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Weirich-Schwaiger H; Utermann B; Egger K; Brenneis C; Granata R; Boesch S; Poewe W; Wenning GK
Mov Disord; 2006 Jul; 21(7):1043-7. PubMed ID: 16570300
[TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor imaging of deep gray matter brain structures: effects of age and iron concentration.
Pfefferbaum A; Adalsteinsson E; Rohlfing T; Sullivan EV
Neurobiol Aging; 2010 Mar; 31(3):482-93. PubMed ID: 18513834
[TBL] [Abstract][Full Text] [Related]
19. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
Nanetti L; Contarino VE; Castaldo A; Sarro L; Bachoud-Levi AC; Giavazzi M; Frittoli S; Ciammola A; Rizzo E; Gellera C; Bruzzone MG; Taroni F; Grisoli M; Mariotti C
Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
[TBL] [Abstract][Full Text] [Related]
20. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.
Wang JY; Hagerman RJ; Rivera SM
Mov Disord; 2013 Aug; 28(9):1278-84. PubMed ID: 23649693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
